Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AstraZeneca patents new protein kinase inhibitors

Jan. 10, 2012

New Evestra progesterone receptor inhibitor shows potential as breast cancer therapy

Jan. 10, 2012

Phase I/II data presented on SAR-245408-based combination regimens in metastatic breast cancer

Jan. 10, 2012

Ongoing phase I/II trial assesses combinations of letrozole with SAR-245408 and SAR-245409

Jan. 10, 2012

Novel approach leads to discovery of NME that prevents tumor invasion

Jan. 10, 2012

New auristatin derivatives for cancer prepared at Bayer Schering Pharma

Jan. 10, 2012

First patient vaccinated in study of DPX-Survivac cancer vaccine

Jan. 9, 2012

Novel protein-tyrosine kinase inhibitors synthesized in China

Jan. 9, 2012

Phase I/II study evaluates rintatolimod as adjuvant for HER2 vaccine

Jan. 9, 2012

Dosing of VT-464 begins in phase I/II study

Jan. 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...